Top Markets
#1 Wiki Cat Wiki Cat +55.96%
#2 Siren Siren +35.80%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.44%
#4 Ribbita by Virtuals Ribbita by Virtuals +22.19%
#5 PulseChain PulseChain +18.13%
#6 Velvet Velvet +17.48%
#7 KUB Coin KUB Coin +16.83%
#8 OpenEden OpenEden +16.69%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.55%
#10 The Grays Currency The Grays Currency +16.32%
Coin of the day
Wiki Cat Wiki Cat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Classifica tra le azioni #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Prezzo delle azioni
$0.01084256
Capitalizzazione di mercato
$13.87M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
1.70%
Paese
NZ
Scambia BLIS Technologies Limited (BLT)

Categoria

Healthcare
Ricavi di BLIS Technologies Limited (BLT)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BLIS Technologies Limited, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per BLIS Technologies Limited da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE